PRF Technologies Ltd. SEC filings PRFX
PRF Technologies Ltd. has 263 filings in SEC EDGAR's recent list, going back to Feb 3, 2020. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 3, 2026 | — |
| EFFECT | Filing | Jun 29, 2026 | — |
| CORRESP | Letter to the SEC | Jun 29, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2026 | — |
| EFFECT | Filing | May 19, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 18, 2026 | — |
| EFFECT | Filing | May 9, 2025 | — |
| CORRESP | Letter to the SEC | May 7, 2025 | — |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| EFFECT | Filing | Dec 12, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 11, 2024 | — |
| EFFECT | Filing | Oct 3, 2024 | — |
| CORRESP | Letter to the SEC | Oct 1, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2024 | — |
| EFFECT | Filing | Aug 29, 2024 | — |
| EFFECT | Filing | Apr 15, 2024 | — |
| EFFECT | Filing | Mar 13, 2024 | — |
| EFFECT | Filing | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Jan 18, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2024 | — |
| EFFECT | Filing | Sep 1, 2023 | — |
| CORRESP | Letter to the SEC | Aug 30, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2023 | — |
| EFFECT | Filing | Sep 13, 2021 | — |
| CORRESP | Letter to the SEC | Sep 13, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2021 | — |
| EFFECT | Filing | Sep 8, 2021 | — |
| EFFECT | Filing | Apr 9, 2021 | — |
| CORRESP | Letter to the SEC | Apr 8, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2021 | — |
| EFFECT | Filing | Mar 23, 2021 | — |
| D | Filing | Mar 19, 2021 | — |
| EFFECT | Filing | Aug 31, 2020 | — |
| CERT | Filing | Aug 31, 2020 | — |
| 8-A12B | For registration of certain classes | Aug 31, 2020 | — |
| CORRESP | Letter to the SEC | Aug 27, 2020 | — |
| CORRESP | Letter to the SEC | Aug 27, 2020 | — |
| CORRESP | Letter to the SEC | Aug 10, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2020 | — |
| CORRESP | Letter to the SEC | Aug 5, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2020 | — |
| CORRESP | Letter to the SEC | Jun 30, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2020 | — |
| DRSLTR | Filing | Jun 2, 2020 | — |
| DRS/A | Filing | Jun 2, 2020 | — |
| UPLOAD | Letter from the SEC | May 22, 2020 | — |
| DRSLTR | Filing | May 12, 2020 | — |
| DRS/A | Filing | May 12, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2020 | — |
| DRSLTR | Filing | Feb 3, 2020 | — |
| DRS | Filing | Feb 3, 2020 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRFX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1801834
- Former names
- PAINREFORM LTD. (until Jan 20, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.